Microdeletion in the FMR-1 gene: An apparent null allele using routine clinical PCR amplification [5]

Journal of Medical Genetics

Volumn 38, Issue 9, 2001, Pages 624-629

  Hegde, M R ^a   Chong, B ^a   Fawkner, M ^a   Lambiris, N ^a   Peters, H ^a   Kenneson, A ^a   Warren, S T ^a   Love, D R ^a   McGaughran, J ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; DNA; GUANINE;

ALLELE; CASE REPORT; CYTOGENETICS; DNA DETERMINATION; DNA SEQUENCE; FRAGILE X SYNDROME; GENE DELETION; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LETTER; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; TRINUCLEOTIDE REPEAT;

ALLELES; BASE SEQUENCE; BLOTTING, WESTERN; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE DELETION; GENETIC SCREENING; HUMANS; INFANT; INFANT, NEWBORN; MALE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEDIGREE; POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; SEQUENCE DELETION; TRANS-ACTIVATORS; TRINUCLEOTIDE REPEATS;

EID: 0034840316     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (39)

1. Advances in molecular analysis of fragile X syndrome
2. Prevalence of fragile X syndrome
3. FRAXA and FRAXE prevalence in patients with nonspecific mental retardation in the Hellenic population
4. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox
5. Fragile X syndrome: Diagnostic and carrier testing
6. Trinucleotide repeat expansions in neurological disease
7. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome
8. Physical mapping across the fragile X: Hypermethylation and clinical expression of the fragile X syndrome
9. Absence of expression of the FMR-1 gene in fragile X syndrome
10. DNA methylation represses FMR-1 transcription in fragile X syndrome
11. Translational suppression by trinucleotide repeat expansion at FMR1
12. A point mutation in the FMR-1 gene associated with fragile X mental retardation
13. Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome
14. Fragile X syndrome without CCG amplification has an FMR1 deletion
15. An extensive de novo deletion removing FMR1 in a patient with mental retardation and the fragile X syndrome phenotype
16. Spontaneous deletion in the FMR1 gene in a patient with fragile X syndrome and cherubism
17. An atypical case of fragile X syndrome caused by a deletion that includes the FMR1 gene
18. A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome
19. A de novo deletion in FMR1 in a patient with developmental delay
20. A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome
21. Male with typical fragile X phenotype is deleted for part of the FMR1 gene and for about 100 kb of upstream region
22. Two new cases of FMR1 deletion associated with mental impairment
23. The fragile X phenotype in a mosaic male with a deletion showing expression of the FMR1 protein in 28% of the cells
24. Mosaicism of a microdeletion of 486 bp involving the CGG repeat of the FMR1 gene due to misalignment of GTT tandem repeats at chi-like elements flanking both breakpoints and a full mutation
25. Heritable fragile sites on human chromosomes. II. Distribution, phenotypic effects, and cytogenetics
26. A female compound heterozygote (pre- and full mutation) for the CGG FMR1 expansion
27. Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein
28. Expression of fanctional eIF4e human: Purification, detailed characterization, and its use in isolating eIF-4e binding proteins
29. The FMR1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation
30. Rapid antibody test for fragile X syndrome
31. Rapid antibody test for diagnosing fragile X syndrome: A validation of the technique
32. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population
33. Immunological detection of the messenger RNA cap-binding protein
34. Identification and quantification of levels of protein synthesis initiation factors in crude HeLa cell lysates by two-dimensional polyacrylamide gel electrophoresis
35. Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggests a role in translational control
36. Protein synthesis initiation factor eIF-1A is a moderately abundant RNA-binding protein
37. Polymerase chain reaction analysis of fragile X mutations
38. Null alleles at the Huntington disease locus: Implications for diagnostics, and CAG repeat instability
39. Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6